Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment

Pediatric Nephrology

Volumn 32, Issue 8, 2017, Pages 1369-1375

  Atmaca, Mustafa ^a   Gulhan, Bora ^a   Korkmaz, Emine ^a   Inozu, Mihriban ^a   Soylemezoglu, Oguz ^b   Candan, Cengiz ^c   Bayazıt, Aysun Karabay ^d   Elmacı, Ahmet Midhat ^e   Parmaksiz, Gonul ^f   Duzova, Ali ^a   Besbas, Nesrin ^a   Topaloglu, Rezan ^a   Ozaltin, Fatih ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^d CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^e Section of Pediatric Surgery   (Turkey)

^f BASKENT UNIVERSITY   (Turkey)

Author keywords

ADCK4 mutation; Adolescent; Chronic kidney disease; CoQ10 supplementation; Nephrotic syndrome

Indexed keywords

UBIDECARENONE; AARF DOMAIN CONTAINING KINASE 4, HUMAN; GLUCOCORTICOID; PROTEIN KINASE; UBIQUINONE; VITAMIN;

ADCK4 GENE; ADOLESCENT; ADULT; ALBUMINURIA; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; DRUG EFFICACY; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT HISTORY OF TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; YOUNG ADULT; ANALOGS AND DERIVATIVES; DIFFERENTIAL DIAGNOSIS; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; GLOMERULUS FILTRATION RATE; KIDNEY; MUTATION; NEPHROTIC SYNDROME; PATHOLOGY; TIME FACTOR; TREATMENT OUTCOME; URINE;

ADOLESCENT; ADULT; ALBUMINURIA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MUTATION; NEPHROTIC SYNDROME; PROTEIN KINASES; TIME FACTORS; TREATMENT OUTCOME; TURKEY; UBIQUINONE; VITAMINS; YOUNG ADULT;

EID: 85015950040     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-017-3634-3     Document Type: Article

References (12)

1. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639
2. Smith JM, Stablein DM, Munoz R, Hebert D, McDonald R (2007) Contributions of the Transplant Registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 11:366–373
3. Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 31:1802–1813
4. Tran UC, Clarke C (2007) Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion 7(Suppl):S62–S71
5. Ozaltin F (2014) Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies. Pediatr Nephrol 29:961–969
6. Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Böckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F (2013) ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest 123:5179–5189
7. Korkmaz E, Lipska-Ziętkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, Schnaidt S, Gucer S, Kaymaz F, Arici M, Dinckan A, Mir S, Bayazit AK, Emre S, Balat A, Rees L, Shroff R, Bergmann C, Mourani C, Antignac C, Ozaltin F, Schaefer F, PodoNet Consortium (2016) ADCK4-associated glomerulopathy causes adolescence-onset FSGS. J Am Soc Nephrol 27:63–68
8. Montini G, Malaventura C, Salviati L (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358:2849–2850
9. Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, McLaughlin HM, Airik R, Vlangos CN, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, Rötig A, Nürnberg G, Becker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, Müller D, Beissert A, Mir S, Berdeli A, Varpizen S, Zenker M, Matejas V, Santos-Ocaña C, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, Nürnberg P, Clarke CF, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013–2024
10. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium (2015) Spectrum of steroid resistant and congenital nephrotic syndrome in children: The PodoNet Registry Cohort. Clin J Am Soc Nephrol 10:592–600
11. The ESCAPE Trial Group (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650
12. Wühl E, Mehls O, Schaefer F, Escape Trial Group (2004) Antihypertensive and antiproteinuric efficacy of Ramipril in children with chronic renal failure. Kidney Int 66:768–776